PAI-1, which is encoded by the SERPINE1 gene, acts as inhibitor of tissue plasminogen activator (tPA) and urokinase plasminogen activator (uPA) and has been described to correlate with poor patient prognosis of different tumor types including breast cancer [28, 29]. Here, SERPINE1 is linked to neoplasm.